These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 25899797

  • 21. Short-term side effects of stimulant medication are increased in preschool children with attention-deficit/hyperactivity disorder: a double-blind placebo-controlled study.
    Firestone P, Musten LM, Pisterman S, Mercer J, Bennett S.
    J Child Adolesc Psychopharmacol; 1998; 8(1):13-25. PubMed ID: 9639076
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. A randomized crossover clinical study showing that methylphenidate-SODAS improves attention-deficit/hyperactivity disorder symptoms in adolescents with substance use disorder.
    Szobot CM, Rohde LA, Katz B, Ruaro P, Schaefer T, Walcher M, Bukstein O, Pechansky F.
    Braz J Med Biol Res; 2008 Mar; 41(3):250-7. PubMed ID: 18327433
    [Abstract] [Full Text] [Related]

  • 24. Pindolol and methylphenidate in children with attention-deficit hyperactivity disorder. Clinical efficacy and side-effects.
    Buitelaar JK, van der Gaag RJ, Swaab-Barneveld H, Kuiper M.
    J Child Psychol Psychiatry; 1996 Jul; 37(5):587-95. PubMed ID: 8807439
    [Abstract] [Full Text] [Related]

  • 25. [Supervised off-label prescribing of methylphenidate in adult ADHD].
    Carton L, Dondaine T, Deheul S, Marquié C, Brigadeau F, Amad A, Devos D, Danel T, Bordet R, Cottencin O, Gautier S, Ménard O.
    Encephale; 2019 Feb; 45(1):74-81. PubMed ID: 30122296
    [Abstract] [Full Text] [Related]

  • 26. National survey of adherence, efficacy, and side effects of methylphenidate in children with attention-deficit/hyperactivity disorder in Taiwan.
    Gau SS, Chen SJ, Chou WJ, Cheng H, Tang CS, Chang HL, Tzang RF, Wu YY, Huang YF, Chou MC, Liang HY, Hsu YC, Lu HH, Huang YS.
    J Clin Psychiatry; 2008 Jan; 69(1):131-40. PubMed ID: 18312048
    [Abstract] [Full Text] [Related]

  • 27. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].
    Golubchik P, Sever J, Weizman A.
    Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124
    [Abstract] [Full Text] [Related]

  • 28. The efficacy of 2 different dosages of methylphenidate in treating adults with attention-deficit hyperactivity disorder.
    Bouffard R, Hechtman L, Minde K, Iaboni-Kassab F.
    Can J Psychiatry; 2003 Sep; 48(8):546-54. PubMed ID: 14574830
    [Abstract] [Full Text] [Related]

  • 29. Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability.
    Simonoff E, Taylor E, Baird G, Bernard S, Chadwick O, Liang H, Whitwell S, Riemer K, Sharma K, Sharma SP, Wood N, Kelly J, Golaszewski A, Kennedy J, Rodney L, West N, Walwyn R, Jichi F.
    J Child Psychol Psychiatry; 2013 May; 54(5):527-35. PubMed ID: 22676856
    [Abstract] [Full Text] [Related]

  • 30. Prediction of sleep side effects following methylphenidate treatment in ADHD youth.
    Yoo JH, Sharma V, Kim JW, McMakin DL, Hong SB, Zalesky A, Kim BN, Ryan ND.
    Neuroimage Clin; 2020 May; 26():102030. PubMed ID: 31711956
    [Abstract] [Full Text] [Related]

  • 31. Opiate Antagonists Do Not Interfere With the Clinical Benefits of Stimulants in ADHD: A Double-Blind, Placebo-Controlled Trial of the Mixed Opioid Receptor Antagonist Naltrexone.
    Spencer TJ, Bhide P, Zhu J, Faraone SV, Fitzgerald M, Yule AM, Uchida M, Spencer AE, Hall AM, Koster AJ, Biederman J.
    J Clin Psychiatry; 2018 May; 79(1):. PubMed ID: 28640990
    [Abstract] [Full Text] [Related]

  • 32. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ, Baird G, Pityaratstian N, Tavare E, Gringras P.
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [Abstract] [Full Text] [Related]

  • 33. Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial.
    Zarinara AR, Mohammadi MR, Hazrati N, Tabrizi M, Rezazadeh SA, Rezaie F, Akhondzadeh S.
    Hum Psychopharmacol; 2010 Nov; 25(7-8):530-5. PubMed ID: 20860068
    [Abstract] [Full Text] [Related]

  • 34. Child and parent perceptions of stimulant medication treatment in attention deficit hyperactivity disorder.
    Efron D, Jarman FC, Barker MJ.
    J Paediatr Child Health; 1998 Jun; 34(3):288-92. PubMed ID: 9633980
    [Abstract] [Full Text] [Related]

  • 35. Drug Holidays From ADHD Medication: International Experience Over the Past Four Decades.
    Ibrahim K, Donyai P.
    J Atten Disord; 2015 Jul; 19(7):551-68. PubMed ID: 25253684
    [Abstract] [Full Text] [Related]

  • 36. Efficacy of theophylline compared to methylphenidate for the treatment of attention-deficit hyperactivity disorder in children and adolescents: a pilot double-blind randomized trial.
    Mohammadi MR, Kashani L, Akhondzadeh S, Izadian ES, Ohadinia S.
    J Clin Pharm Ther; 2004 Apr; 29(2):139-44. PubMed ID: 15068402
    [Abstract] [Full Text] [Related]

  • 37. Combined methylphenidate and atomoxetine pharmacotherapy in attention deficit hyperactivity disorder.
    Ozbaran B, Kose S, Yuzuguldu O, Atar B, Aydin C.
    World J Biol Psychiatry; 2015 Apr; 16(8):619-24. PubMed ID: 26223958
    [Abstract] [Full Text] [Related]

  • 38. Efficacy and safety of Ritalin LA, a new, once daily, extended-release dosage form of methylphenidate, in children with attention deficit hyperactivity disorder.
    Biederman J, Quinn D, Weiss M, Markabi S, Weidenman M, Edson K, Karlsson G, Pohlmann H, Wigal S.
    Paediatr Drugs; 2003 Apr; 5(12):833-41. PubMed ID: 14658924
    [Abstract] [Full Text] [Related]

  • 39. An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Children with Attention-Deficit/Hyperactivity Disorder.
    Shang CY, Pan YL, Lin HY, Huang LW, Gau SS.
    J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):566-73. PubMed ID: 26222447
    [Abstract] [Full Text] [Related]

  • 40. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
    Bricard C, Boidein F.
    Encephale; 2001 Sep; 27(5):435-43. PubMed ID: 11760693
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.